Examines 592 publications in Indian chronic obstructive pulmonary disease (COPD) research, as indexed in Scopus database during [2003][2004][2005][2006][2007][2008][2009][2010][2011][2012], witnessing an annual average growth rate of 30.38% and international collaborative publication share of 12.67%. The global share of Indian COPD research was 1.46% during 2003-2012, which increased from 1.07% to 1.72% from 2003-2007 to 2008-2012. Medicine contributed the largest publications share (77.70%) in Indian COPD research, followed by biochemistry, genetics and molecular biology (16.89%), pharmacology, toxicology and pharmaceutics (14.36%), environment science (2.87%) and immunology and microbiology (2.70%) during 2003-2012. The 10 most productive organizations and authors in Indian COPD research contributed 30.07% and 17.74% share each to its cumulative publications output during 2003-2012 and have registered an average productivity per author of 17.8 and 10.50, an average citation impact per paper of 3.57 and 5.36 and an average h-index value of 4.60 and 4.50. The authors suggest the need to increase India's research efforts, improve its research quality and increase its international collaborative research efforts. India also needs to develop a National COPD Prevention and Control Programme, with a major thrust on setting up infrastructure for early and accurate diagnosis, appropriate treatment and rehabilitation programmes, generating new knowledge in COPD and dissemination of knowledge regarding prevention, diagnosis, treatment and rehabilitation to healthcare providers in India.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is part of respiratory diseases, which include inflammatory lung disease (including asthma, cystic fibrosis, etc.), obstructive lung diseases, restrictive lung diseases or respiratory track infections (including pneumonia), malignant tumors of the respiratory system, pleural cavity disease, pulmonary vascular disease and pulmonary hyperplasia.
[1] COPD has been variously labeled in the past as "chronic obstructive
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lung disease," "chronic obstructive airways disease," "chronic airflow obstruction," "chronic airway (or airflow) limitation (CAL)" or simply as "chronic bronchitis" and "emphysema." [2] COPD is presently accepted as an overall umbrella term for a variety of clinical disorders with chronic bronchitis at the one end and emphysema at the other end of the spectrum. [3] COPD is a common preventable and treatable disease, is characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. The CAL characteristic of COPD is caused by the mixture of small airways disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), the relative contributions of which vary from person to person. Chronic inflammation causes structural changes and the narrowing of the small airways. Destruction of the lung parenchyma, also by inflammatory processes leads to the loss of alveolar attachments to the small airways and decreases lung elastic recoil, in turn, these changes diminish the ability of the airways to remain open during expiration. Exacerbations and co-morbidities contribute to overall severity of individual patients. The factors associated with damage to the lungs spill into the blood and subsequently cause damage to the heart, skeletal muscles, bones, kidneys and brain. In fact, over two-third of patients with COPD die due to ischemic heart disease, congestive heart failure, hypertension, skeletal muscle dysfunction, weight loss, osteoporosis and kidney failure. Symptoms of COPD include: Dyspnea, chronic cough and chronic sputum production. World-wide the most commonly risk factors are tobacco smoking. Chronic exposure to indoor air pollution due to the burning of biomass fuels in poorly ventilated homes and high levels of ambient air pollution, largely due to motor vehicular and industrial exhausts seem to be the major risk factors for COPD in India. Other risk factors are also not uncommon -occupational exposures (farming, mining, building and construction, stone cutting, leather industry and others), a previous lung tuberculosis, poorly treated chronic asthma, poor nutrition and poor socio-economic status. Outdoor occupational and indoor air pollution -the latter is resulting from the burning of biomass fuels-are other major risk factors. The genetic risk factor that is best documented is a severe heredity deficiency of alpha-1 anti-trypsin. [3] [4] [5] Globally, COPD has emerged as the major cause of morbidity and mortality, expected to become the third most leading cause of death and the fifth leading cause of loss of "disability adjusted life years" as per projection of the Global Burden of Disease Study. [3] According to World Health Organization estimates, 65 million people have moderate to severe COPD. More than 3 million people died of COPD in 2005 corresponding to 5% of all deaths globally, and it is estimated to be the third leading cause of death by 2030. However, it is known that low-and middle-income countries already shoulder much of the burden of COPD with almost 90% of COPD deaths taking place in these countries. [6] Rough estimates suggest that there are 30 million COPD patients in India. India contributes a significant and growing percentage of COPD mortality which is estimated to be amongst the highest in the world; that is, more than 64.7 estimated age-standardized death rate per 100,000 among both sexes. This would translate to about 556,000 in case of India (>20%) out of the world total of 2,748,000 annually. [7] Literature Review
Only few scientometric studies have been conducted in the past on respiratory diseases publications. Among them, García-Río et al. [8] examined the respiratory disease research in European Union, as covered in 38 respiratory journals indexed in MEDLINE database during 1987-1998, with a focus on the number of articles from various countries and their relation with socio-economic data, productivity index, visibility index, expected impact factor and relative impact factor. Rippon et al. [9] investigated 81419 respiratory medicine publications, as covered in SCI during 1996-2001 and these were assigned to 14 subject areas (mainly based on title words) and to 15 Organization for Economic Co-operation and Development countries. Publication outputs were compared with the nation's disease burdens and for the UK, the sources of research funding were investigated. Groneberg-Kloft et al. [10] studied research quantity and quality of two obstructive airway diseases, bronchial asthma and COPD during 20 years period (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) , using Web of Science database. In particular, the research activities of UK and Germany are compared. Chen et al. [11] evaluated the publication output on asthma in children during 1991-2002, using SCI database and focused on language, type of document, country of publications, authorship, publication pattern and the most frequently cited papers. Gupta and Bala [12] examined the asthma research output of India during 1999-2008, using Scopus database and focused on the growth, rank and global publications share, citation impact, share of international collaborative publications (ICPs), contribution of major collaborative partner countries, contribution of various subject fields and characteristics of most productive institutions, authors and high-cited publications.
OBJECTIVES
The main objective of this study is to analyze the Indian and global research output in COPD during 2003-2012 with a view: (i) to study the global publications share and citation impact of top 15 countries, (ii) to study the Indian publication output, its growth and citation impact; (iii) to study the share of international collaborative papers and the share of India's collaborative partner countries; (iv) to study the distribution of publications by different subject sub-fields and by population age groups; (v) to study the publication productivity and citation impact of top 10 Indian organizations and authors; (vi) to study the media of communication of Indians in most productive journals.
METHODOLOGIES AND SOURCE OF DATA
The publication data of 15 most productive countries (including India) in COPD were extracted and downloaded from Scopus International Database (http://www.scopus.com) for the 10 years period (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) . For identifying literature on COPD, a set of keywords was identified and the following search strategy (main strategy) (limiting it to country affiliating tag), was used to search and download publication data resulting in 40669 global records and 592 Indian records in COPD during 2003-2012.
Chronic obstructive pulmonary disease literature was classified according to population age groups based on keywords, such as child, adolescents, adults, middle aged and aged. For analyzing publications by sub-fields, database classification as provided in Scopus database has been used. For analyzing significant institutions, authors and journals, separate search strategies were developed, which later combined with the main search strategy leading to the generation of the desired output. For citations data, 3 years, 2 years and 1 year citation window has been used for computing average citations per paper in COPD research during 2003-2010, 2011 and 2012.
ANALYSIS

Global Publication Share of Top 20 Most Productive Countries
The global publication share of top 20 most productive countries in COPD varies from 1.27% to 24.52% during th rank), Switzerland, Belgium, Sweden, Turkey, Brazil, India, Poland, Denmark and Greece (from 1.27% to 1.96% publication share and rank from 12 th to 20 th ). The publication share has increased in USA by 2.1%, followed by China (1.13%), Australia (0.8%), Japan (0.75%), Brazil (0.73%), India (0.65%), Spain (0.56%), Turkey (0.48%), Greece (0.45%), Canada (0.40%), Denmark (0.36%), Italy (0.18%), The Netherlands (0.09%), Switzerland (0.08%), Belgium (0.05%) and Germany (0.05%), as against decrease in France (0.57%), Sweden (0. Table 5 ].
Profile of Top 10 Most Productive Indian Organizations
The total Indian research output in COPD was published from 180 organizations, of which the top 10 have published 9-43 publications each and together contributed 30.07% (178 publications) share in the Indian cumulative publications output during 2003-2012. The scientometric profile of these 10 organizations is presented in 
Profile of Top 10 Most Productive Indian Authors
The top 10 most productive authors in Indian research in COPD have published 10-17 publications each and together contributed 17.74% (105 publications) share in the cumulative publications output of India during 2003-2012. The scientometric profile of these 10 authors is presented in Table 7 . Three authors have registered higher publication productivity per author than the group average of 10.50 of all authors: S.K. Chhabra (17 publications), S.K. Jindal (15 publications) and R. Agarwal (11 publications). Four authors (7), S.K. Chhabra (6), S.K. Jindal (6), S.G. Dastidar (6) and R. Agarwal (5).
Mode of Communication
Of the total 592 Indian publications on COPD, 498 publications were published in 161 journals during 2003-2012. The list of top 10 journals along with their output is given in Compared to the mortalities in India because of COPD, the present Indian research efforts are very small. Therefore, India needs to increase its research efforts substantially, improve its research quality and increase its international collaborative research efforts. In addition, India needs a National COPD Prevention and Control Programme, with a major thrust on: (a) Setting up appropriate healthcare services infrastructure in India for early and accurate diagnosis, appropriate treatment and rehabilitation programmes, (b) generating new knowledge in COPD that will be relevant to India's needs through properly designed and funded research studies and (c) dissemination of knowledge regarding prevention, diagnosis, treatment and rehabilitation to healthcare providers in India so that they can improve the quality of care of patients with COPD. For this, physicians, researchers, policy makers, medical educators and healthcare providers will need to come together, devise and implement strategies that will be effective and sustainable.
